Results 41 to 50 of about 50,848 (283)

Verification of cell cycle-associated cyclin-dependent kinases facilitated prostate cancer progression by integrated bioinformatic analysis and experimental validation

open access: yesHeliyon, 2022
Introduction: Cell cycle-associated cyclin-dependent kinases (ccCDKs) are essential regulators known to control cell division and facilitate tumorigenesis and progression.
Yean Huang   +8 more
doaj   +1 more source

The role of CDK in the initiation step of DNA replication in eukaryotes

open access: yesCell Division, 2007
Cyclin-dependent kinases (CDKs) regulate the progression of the cell cycle in eukaryotes. One of the major roles of CDK is to promote chromosomal DNA replication.
Tak Yon-Soo   +2 more
doaj   +1 more source

Table_1_Identification of the Effects of Chondroitin Sulfate on Inhibiting CDKs in Colorectal Cancer Based on Bioinformatic Analysis and Experimental Validation.pdf

open access: yes, 2021
With a high occurrence rate and high mortality, the treatment of colorectal cancer (CRC) is increasingly attracting the attention of scholars. Hub genes that determine the phenotypes of CRC become essential for targeted therapy. In the present study, the
Takuya Miyakawa (246192)   +6 more
core   +1 more source

Identification and structural-functional analysis of cyclin-dependent kinases of the cattle tick Rhipicephalus (Boophilus) microplus. [PDF]

open access: yesPLoS ONE, 2013
Cyclin-dependent kinases (CDKs) are a family of serine/threonine kinases essential for cell cycle progression. Herein, we describe the participation of CDKs in the physiology of Rhipicephalus microplus, the southern cattle tick and an important disease ...
Helga Gomes   +12 more
doaj   +1 more source

Unveiling The Noncanonical Activation Mechanism of CDKs: Insights From Recent Structural Studies [PDF]

open access: yes, 2023
The Cyclin-dependent kinases (CDKs) play crucial roles in a range of essential cellular processes. While the classical two-step activation mechanism is generally applicable to cell cycle-related CDKs, both CDK7 and CDK8, involved in transcriptional ...
Tsai, Kuang-Lei, Li, Tao, Tang, Hui-Chi
core   +1 more source

Two co-evolutionary scenarios between human cyclins and human CDKs.

open access: yes, 2023
The co-phylogenies were realized using Jane [170] (A) and TreeMap [174] (B). (A) Cyclins (black lines) and CDKs (blue lines) that cluster together depict an interaction (the cyclin can bind the CDK to activate it).
Emma U. Hammarlund (10966182)   +3 more
core   +1 more source

Oncogenic and Tumor Suppressive Components of the Cell Cycle in Breast Cancer Progression and Prognosis

open access: yesPharmaceutics, 2021
Cancer, a disease of inappropriate cell proliferation, is strongly interconnected with the cell cycle. All cancers consist of an abnormal accumulation of neoplastic cells, which are propagated toward uncontrolled cell division and proliferation in ...
Dharambir Kashyap   +4 more
doaj   +1 more source

The molecular aspects in prostatic cancer, unraveling the role of CDKs in prostate cancer progression. [PDF]

open access: yesDiscov Oncol
Background Prostate cancer (PCa) is one of the leading causes of morbidity and mortality in the world, it becomes imperative to investigate the molecular mechanisms underlying practical therapeutic approaches. Cyclin-dependent kinases (CDKs) are critical
Farjami Z   +4 more
europepmc   +2 more sources

The origin of CDK regulation [PDF]

open access: yesNature Cell Biology, 2001
The initiation of DNA replication is restrained by Cip/Kip proteins that inhibit Cdk2. Degradation of Xenopus Xic1, a Kip1 orthologue, is dependent on its recruitment to replication origins. This ensures that activation of Cdk2 and (subsequent initiation of replication) is co-ordinately regulated at, and localised to, replication origins.
Li, Anatoliy, Blow, J. Julian
openaire   +3 more sources

A DNA G‐Quadruplex‐Targeting Ligand Suppresses c‐MYC Expression: Implications for Gemcitabine‑Resistant Pancreatic Cancer

open access: yesAngewandte Chemie, EarlyView.
PQB‐4, a fluorescent small‐molecule ligand that targets c‐MYC DNA G‐quadruplexes (G4s), showed marked synergy with gemcitabine in resistant PANC‐1 cells (CI = 0.027). In vivo, the ligand reduced tumor weight by 44% in a PANC‐1 xenograft model. These results highlight the therapeutic potential of c‐MYC DNA G4‐targeting ligands for treating gemcitabine ...
Bo‐Xin Zheng   +10 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy